GO FUND IT NOW

UNIVERSITY OF TEXAS TYLER

Engineering Natural Killer Cell Derived Extracellular Vesicular Nanodrug for Tumor Targeted Bioimaging and Therapy

Engineering Natural Killer Cell Derived Extracellular Vesicular Nanodrug for Tumor Targeted Bioimaging and Therapy is a funding opportunity from UNIVERSITY OF TEXAS TYLER, up to 441000, closing April 30, 2028.

Funder
UNIVERSITY OF TEXAS TYLER
Funding
441000
Deadline
Apr 30, 2028
(639d left)

Overview

Natural Killer (NK) cells are large granular lymphocytes that belong to the innate immune system, and their major function is to provide host defense against microbial infections and tumors by immune surveillance of the cell surface to find the abnormal expression of major histocompatibility complex (MHC) class I…

Engineering Natural Killer Cell Derived Extracellular Vesicular Nanodrug for Tumor Targeted Bioimaging and Therapy | Go Fund It Now